The aim of our study was to identify physical and mental health-related quality of life (HRQoL) trajectories after a prostate cancer diagnosis and systematically characterize trajectories by behaviours and prognostic factors. Prostate cancer survivors (n 5 817) diagnosed between 1997 and 2000 were recruited between 2000 and 2002 into a prospective repeated measurements study. Behavioural/prognostic data were collected through in-person interviews and questionnaires. HRQoL was collected at three post-diagnosis time-points, approximately 2 years apart using the Short Form (SF)236 validated questionnaire. To identify physical and mental HRQoL trajectories, group-based trajectory modelling was undertaken. Differences between groups were evaluated by assessing influential dropouts (mortality/poor health), behavioural/prognostic factors at diagnosis or during the follow-up. Three trajectories of physical HRQoL were identified including: average-maintaining HRQoL (32.2%), low-declining HRQoL (40.5%) and very low-maintaining HRQoL (27.3%). In addition, three trajectories for mental HRQoL were identified: average-increasing HRQoL (66.5%), above average-declining HRQoL (19.7%) and low-increasing HRQoL (13.8%). In both physical and mental HRQoL, dropout from mortality/poor health differed between trajectories, thus confirming HRQoL and mortality were related. Furthermore, increased Charlson comorbidity index score was consistently associated with physical and mental HRQoL group membership relative to average maintaining groups, while behaviours such as time-varying physical activity was associated with physical HRQoL trajectories but not mental HRQoL trajectories. It was possible to define three trajectories of physical and mental HRQoL after prostate cancer. These data provide insights regarding means for identifying subgroups of prostate cancer survivors with lower or declining HRQoL after diagnosis whom could be targeted for interventions aimed at improving HRQoL.
Introduction
Globally the burden of prostate cancer is on the rise, with estimates of 1.1 million new cases 1 and 3.9 million prevalent cases of prostate cancer worldwide in 2012. 2 Screening programs largely driven by the Prostate-Specific Antigen (PSA) testing introduced in the early 1990s have increased detection of prostate cancer, specifically in developed countries. 1, 3 Early detection was believed to reduce prostate cancer mortality. 4 However, early detection may also result in over-diagnosis and over-treatment of potentially non-life threatening prostate cancer. 5 The consequences of treating men with non-life threatening prostate cancer are serious since long-term residual side effects, reduced physical functioning (e.g., urinary and sexual function), a compromised mental state and reduced health-related quality of life (HRQoL) 6-10 often occur in this population. While HRQoL outcomes have been well documented after diagnosis of prostate cancer, most research studies focus on impacts of different treatments 11 or supportive interventions 12 on HRQoL over time. Moreover, studies have examined HRQoL changes with repeated measurements long-term after diagnosis of prostate cancer. [13] [14] [15] [16] [17] However, to our knowledge, studies that examined physical and mental HRQoL changes in prostate cancer survivors have made assumptions that the whole study population can be represented by a single pattern of HRQoL, by measuring average changes in HRQoL. Nonetheless, it is unknown if there are distinct subgroups of prostate cancer survivors with different HRQoL patterns following diagnosis. Subtle differences may be missed when examining average patterns of HRQoL over time. Group-Based Trajectory Modeling (GBTM) is an innovative analytic method that allows researchers to determine longitudinal subgroups within a population without making distribution assumptions. 18 To date, only two studies have utilized GBTM to evaluate surgical outcomes following prostatectomy in prostate cancer survivors including urinary function 19 and sexual function. 20 To our knowledge, GBTM has never been applied to physical and mental HRQoL in a prostate cancer population. The primary objective of this prospective cohort study was to determine HRQoL trajectory patterns in prostate cancer survivors. We hypothesized that there would be more than one and up to four trajectory groups of physical and mental HRQoL in our study population up to 10 years following prostate cancer diagnosis based on sample size and previous research on other HRQoL trajectory groups found in prostate cancer survivors. 19, 20 A secondary objective was to characterize trajectory groups systematically by analyzing common prognostic and behavioural factors associated with prostate cancer. We hypothesized that factors associated with negative prognosis would be associated with low HRQoL groups relative to any high HRQoL group.
Materials and Methods

Study sample
This prostate cancer cohort study in Alberta, Canada has been previously published in detail elsewhere. 21 Briefly, initial recruitment of prostate cancer cases (through the Alberta Cancer Registry) was carried out in a population-based casecontrol study (1997) (1998) (1999) (2000) and participants were re-contacted for consent to enroll in the prospective cohort study between the years 2000 and 2002. Telephone interviews were completed at the first follow-up to obtain physical activity data and a questionnaire was mailed to participants to obtain HRQoL data. Subsequently, at second and third follow-ups, selfadministered questionnaires were sent through the mail to obtain updated physical activity and HRQoL data. Other behavioural and prognostic information was obtained from the prior case-control study 25 through inperson interviews. Variables obtained at prostate cancer diagnosis and used in our study included: average total energy intake (g/day), average alcohol intake (g/year), smoking status, Body Mass Index (BMI) (kg/m 2 ), age in years, aggressive vs. non-aggressive disease (>stage II or Gleason score >8
26
), whether they had a prostatectomy, radiation therapy, hormone therapy and number of comorbidities based on the Charlson co-morbidity index score. 27 The Charlson comorbidity index identifies past history of the following medical conditions: cardiac diseases and risk factors, pulmonary diseases, stomach diseases, renal problems, bone and joint health, inflammatory diseases, auto-immune diseases and disclosure of any other major health conditions not included in the above list (open ended question). In addition, postdiagnosis past year physical activity (MET-hr/week/year) collected at three separate follow-ups was used in these analyses. 21 
Statistical analysis
Identifying trajectory groups. The analysis utilized GBTM (Traj for Stata V R ), 28 which uses finite mixture modelling to approximate unknown distributions of trajectories across a study population. Censored normal or Tobit models were used to estimate trajectories of physical and mental HRQoL over the post-diagnosis period (2000-2007 for active data collection) in this cohort of prostate cancer survivors. In the model selection process, the Bayesian Information Criterion (BIC) was utilized to determine the best model underlying the group selection and functional form. 18 The BIC was used for model selection within a finite set of models and is based on the likelihood function plus a penalty term for the number of parameters in the model. 29 BIC values balance model fit with model complexity and the closer the negative BIC value is to zero, the better is the fit of the model. Other supplemental criteria were also implemented for model selection including: (1) all trajectory groups encompassed >10% of the total sample, (2) all trajectories were distinct from one another (visual assessment of trajectory figures looking for nonoverlapping confidence intervals (CI)) and (3) posterior probabilities of group membership were >0.7.
18 Posterior probabilities represent the average probability that the trajectory group each participant was assigned to is the most appropriate group selection and model fit. Model selection is a multistep procedure. First, we determined the most appropriate number of trajectories for the physical and mental HRQoL data by fitting models with up to four trajectory groups. A priori, we hypothesized that four groups would be the maximum number of groups tested for model fit according to the sample size, to avoid over-fitting the data and as suggested by other research on HRQoL trajectories in prostate cancer survivors. 19, 20 Second, the functional form of the trajectory groups (linear or quadratic) was evaluated to obtain a base model for physical and mental HRQoL trajectory groups separately. Interpretations, including naming conventions of the physical and mental HRQoL trajectory groups were based on the SF-36 mean score 5 50 and standard deviation 5 10. For example, an "average" trajectory group had a baseline mean score of or close to 50, while a "low" trajectory was <50. Once the model trajectory groups were established, testing for influential observations and determining characteristics of trajectory groups followed. 18 There was substantial loss to follow-up, therefore, we included a logistic regression model estimating the probability of dropping out within each trajectory group dependent on the two previous scores. 30 If differential dropout was present between groups (>10%), dropout was considered influential and included in the final models.
Characteristics of trajectory groups. Descriptive characteristics for each physical and mental HRQoL trajectory group were assessed for initial differences between groups. Then, a priori selected behavioural and prognostic factors were evaluated to characterize physical and mental HRQoL trajectory group membership using multivariable multinomial logistic regression. Multivariable models included the following prognostic and behavioural risk factors: age at diagnosis (years), aggressive vs. non-aggressive disease at diagnosis (Stage >II or Gleason score 8
26
), prostatectomy, radiation therapy, hormone therapy, Charlson co-morbidity index score 27 postdiagnosis, approximate daily energy intake (kcal/day), average alcohol intake (g/year), smoking status (current vs. former/ never 31 ) and BMI at diagnosis (kg/m 2 ). Time-varying physical activity measured up to three time points (MET-hr/week/ year) was evaluated for associations on the group trajectories. The trajectory group with the highest HRQoL was used as the reference category. Relative rate ratios (RRRs) and 95% CIs were produced based on the final adjusted models to represent the multinomial logistic regression comparisons. In addition, models produced estimated mean HRQoL coefficients (intercepts), slope values and physical activity as a time-varying covariate for each trajectory group. In addition, we assessed if there were any within trajectory group dropout characteristic differences.
Sensitivity analyses. Sensitivity analyses were performed on the complete case sample (all three follow-ups completed) and two complete assessments sample (two of the three follow-ups completed), to determine differences in model selection, dropout probabilities and prognostic/behavioural risk factors associated with trajectory group membership. Furthermore, to determine the impact of modelling dropout, multivariable multinomial logistic regression excluding dropout were performed. Then we examined participants who switched trajectory groups with and without modelling dropout to substantiate any shift in trajectory group membership. Furthermore, although we were unable to jointly model physical and mental trajectories together, we examined the associations between physical and mental HRQoL trajectories using Pearson's v 2 test of association. Finally, to explore the possibility of reverse causality, time-lagged models were fit based on previous physical or mental HRQoL scores.
Final trajectory group figures were produced post-model selection. All statistical tests were evaluated at an alpha level of 0.05, using the statistical package Stata v.13 (College Station, TX).
Results
Sample
There were 830 prostate cancer survivors who provided consent to participate in this cohort study. Trajectory models for both physical and mental HRQoL included 817 cancer survivors who had complete first follow-up data. Of these, 595 and 495 participants had complete data at the second and the third follow-up time-points, respectively while 163 participants died during the follow-up ( Supplementary Fig. 1 ).
Trajectory group selection and evaluation
Three physical HRQoL trajectory groups were identified from the GBTM analysis post-diagnosis. Moreover, when assessing functional form, the BIC was closest to zero when all groups were linear, thus the linear function in all groups was considered the most advantageous model fit. All groups included at least 100 survivors (which would equate to 12.2% of the total sample (n 5 817)). A figure of the fully adjusted model was produced (Fig. 1) . Based on the figure, there was a "very lowmaintaining" group with low physical HRQoL mean scores consistent throughout the follow-up, a "low-declining" group with low physical HRQoL scores declining further by the third follow-up and an "average-maintaining" group, with average physical HRQoL scores consistent throughout the follow-up. Baseline intercept mean physical HRQoL scores were estimated as follows: average-maintaining (49.64), lowdeclining (41.68) and very low-maintaining (24.37) ( Table 1) . Posterior group membership probabilities were sufficiently high: 0.86 for the very low-maintaining, 0.79 for the lowdeclining and 0.86 for the average-maintaining groups. In addition, groups were well separated with clear differences of >5 points between the groups. After fitting the base model, we fit models to determine if dropout, behavioural and prognostic factors were associated with model fit and group membership. First, the model including dropout did not improve model fit according to the BIC values. The base model BIC 5 27,228 and the dropout model BIC 5 27,558, in which case, the base model BIC value was closer to zero, thus a better fit. However, when we estimated dropout probabilities for each trajectory group, they were substantially different. The probability of dropping out was more than double (0.42) in the very low-maintaining HRQoL group, compared to 0.15 in the low-declining group and 0.21 in the average-maintaining HRQoL group. Therefore, the attrition process or probability of "dropout" that was based on the two previous outcomes was maintained in the model to allow for this variation across groups. Next, models were fit with all behavioural and prognostic factors in a multivariable multinomial logistic regression analysis. The BIC improved substantially with inclusion of these factors (dropout model without factors527,558 vs. with factors 27,453).
Three mental HRQoL trajectory groups also emerged from the GBTM analysis. The BIC value was the closest to zero in the model with three groups and became unstable with four groups. Linear functions were most appropriate for each trajectory group model fit. Furthermore, all groups included >100 prostate cancer survivors. The BIC associated with the model including dropout for mental HRQoL trajectories did not achieve a better fit (base model 5 27,089 vs. dropout model 5 27,442). A figure from the fully adjusted model was produced (Fig. 2) . According to the figure, there was a "low-increasing" group with low HRQoL scores that increased over time, an "above average-declining" group with above average HRQoL scores that declined substantially over time and a "average-increasing" group with average HRQoL scores that increased slightly over time. The baseline intercept mean coefficients for the mental HRQoL trajectory group scores were: average-increasing (54.59), above averagedeclining (57.32) and low-increasing (25.99) ( Table 1) . The above average-declining group had a negative estimated slope of 26.98, also evident in Figure 2 . Posterior group membership probabilities were 0.91, 0.80 and 0.87 for low-increasing, above average-declining and average-increasing HRQoL groups, respectively. Separation (generally >5 points) was present between the trajectory groups with none of the groups overlapping.
The model including dropout for mental HRQoL trajectories did not achieve a better fit (base model 5 27,089 vs. dropout model 5 27,442). However, like physical HRQoL, the low-increasing mental HRQoL group had significantly higher dropout probabilities (0.38) compared to above average-declining (0.27) and average-increasing (0.20) groups and therefore, was maintained in the models. The BIC value in the mental HRQoL multinomial logistic model including behavioural/prognostic factors improved (dropout model 5 27,442 vs. adjusted model 5 27,425).
Characteristics of trajectory groups
Descriptive characteristics of physical HRQoL trajectory groups are found in Table 2 . The low-declining physical HRQoL group appeared to have the highest number of survivors who had aggressive disease (n 5 70) and radiation therapy (n 5 168). The average-maintaining physical HRQoL group had the largest proportion of survivors who did not receive hormone therapy (50%), did not have a prostatectomy (46%) and were former/never smokers (90%). Median age at diagnosis, Charlson comorbidity index score and BMI increased across average-maintaining, low-declining and very low-maintaining physical HRQoL groups. Alternatively, median physical activity decreased across physical HRQoL groups with the lowest levels in the very low-maintaining physical HRQoL group and the highest levels in the averagemaintaining physical HRQoL group. Table 3 displays descriptive characteristics of mental HRQoL trajectory groups. A large proportion of participants were in the average-increasing mental HRQoL Group (568 out of 817). The above average-declining mental HRQoL group had the highest proportion of participants who received hormone therapy (79%) and had a prostatectomy (91%). Interestingly, the low-increasing group had the lowest proportion of aggressive disease (11%). The above averagedeclining mental HRQoL group had the highest median age at diagnosis (72 years) and highest Charlson comorbidity index score. BMI, average alcohol consumption and total energy intake did not substantially differ between trajectory groups.
When examining the multinomial logistic regression models, a higher Charlson comorbidity index score was statistically significantly associated with very low-maintaining physical HRQoL (RRR: 2.04; 95% CI, 1.66-2.51) and low-declining physical HRQoL (RRR: 1.59; 95% CI, 1.29-1.95) group membership, relative to the average-maintaining physical HRQoL group (Table 4) . Similarly, increased BMI was statistically significantly associated with very low-maintaining and lowdeclining physical HRQoL group membership (very lowmaintaining: RRR: 1.18; 95% CI, 1.09-1.27; low-declining: RRR: 1.09; 95% CI, 1.02-1.17). Other statistically significant associations were found with hormone therapy in very lowmaintaining and low-declining physical HRQoL group membership while prostatectomy, smoking status and age at diagnosis were associated with very low-maintaining physical HRQoL group membership.
Mental HRQoL group membership associations were slightly attenuated compared to physical HRQoL trajectory In mental HRQoL trajectory groups, radiotherapy was statistically significantly protective against dropping out in the average-increasing mental HRQoL group (OR 5 0.50, 95% CI: 0.32-0.78). Having a prostatectomy was adversely significantly associated with dropping out in the average-increasing mental HRQoL group (OR 5 2.12, 95% CI: 1.26-3.58). In addition, current smokers had a three-fold significant increase in dropping out in the low-increasing mental HRQoL group (OR 5 3.48, 95% CI: 1.11-10.88) and almost two-fold significant increase in the average-increasing mental HRQoL group (OR 5 1.91, 95% CI: 1.09-3.35). No other significant associations were found and results were interpreted with caution due to the small sample sizes.
Sensitivity analyses
In sensitivity analyses including survivors with complete follow-up data and those with only two complete follow-up assessments, the model selection and evaluation process did not differ for physical or mental trajectory groups established using all the data and for the final adjusted model fit.
Multinomial logistic regression results were very similar for physical and mental HRQoL trajectories (data not shown). Furthermore, when modelling dropout vs. not, the multinomial logistic regression comparisons relative to the averagemaintaining/increasing HRQoL group were not different for physical or mental HRQoL trajectory groups. In addition, we compared participants who switched trajectory groups when modelling dropout vs. not and there were only 53 "switchers" in the physical HRQoL analysis and 58 "switchers" in the mental HRQoL analysis. Only one survivor in the mental HRQoL trajectory group analysis moved across two groups (low-increasing HRQoL group when modelling dropout then switched to the average-increasing HRQoL group without modelling dropout). The physical and mental HRQoL trajectories were statistically significantly associated based on the Pearson's v 2 test (v 2 5 63.3; r 5 0.24; p < 0.001). For example, survivors with an average-maintaining physical HRQoL trajectory were more likely to have an average-increasing mental HRQoL trajectory (85.8%) compared to survivors with a lowdeclining physical HRQoL trajectory (66.5%) or very lowmaintaining physical HRQoL trajectory (52.9%). see Supplementary Table 1 for details. Finally, we fit time-lagged models and found that modelling previous HRQoL score had a 
Discussion
When utilizing GBTM we identified three physical HRQoL trajectories that were meaningfully different according to clinically relevant thresholds (5 points) 23, 24 up to 10 years following prostate cancer diagnosis. The average-maintaining and very low-maintaining physical HRQoL group scores were relatively consistent across time points. On the other hand, the low-declining physical HRQoL group scores declined by the third time point by approximately five HRQoL points. Prevalence in each of these groups was fairly equal, with the highest prevalence in the low-declining Group (40.5%). We also discovered three mental HRQoL trajectories in our study population of prostate cancer survivors. The above averagedeclining mental HRQoL trajectory had clinically relevant declines over the course of the study follow-up, whereas the low-increasing and average-increasing HRQoL trajectories experienced increases in mental HRQoL scores by the third time-point. Prevalence of the mental HRQoL trajectories was highly concentrated in the average-increasing groups with 66.5% of the population falling into this group relative to the above average-declining (9.7%) and low-increasing (13.8%) groups. In addition, we discovered that the probability of dropout was substantially different in the low physical and mental HRQoL groups compared to the average and above average groups. Furthermore, Charlson comorbidity index score was consistently associated with low and very low HRQoL group membership relative to the average HRQoL groups in both physical and mental trajectories. These associations may be underestimated since psychiatric comorbidities (e.g., depression, anxiety symptoms) which also influence HRQoL and other prostate cancer outcomes 32 were not explicitly collected or examined in the Charlson comorbidity index.
Other studies have focused on disease specific HRQoL in prostate cancer survivors. One study examining urinary function in prostate cancer survivors after radical prostatectomy found three trajectories of HRQoL post-surgery. 19 Although this study focused on recovery patterns with a follow-up up to 12-months post-prostatectomy, age and number of comorbidities were also associated with lower HRQoL group outcomes, similar to our study. The Prostate Cancer Outcomes Study, examined sexual function following radical prostatectomy. 20 Interestingly, their GBTM analysis fit four distinct sexual function trajectories, with age, ethnicity, baseline sexual function and having had nerve-sparing surgery associated with the low HRQoL group. While these studies investigated different HRQoL outcomes, there are some similarities with regard to identifying high HRQoL and low HRQoL subpopulations, similar to our study. Previous research a priori stratified prostate cancer cohorts based on age groups 33 and number of comorbidities. 34 Age groups characterize differences in HRQoL similar to our study, yet, unlike our results, HRQoL scores postdiagnosis did not differ by number of comorbidities. Furthermore, despite treatment differences observed in our study between trajectory groups, mechanisms may be influenced by age of participants and length of follow-up, that cannot be teased apart in observational studies. 35 In addition, we found BMI, smoking and physical activity to be associated with low and very low HRQoL groups to different degrees. For example, time-varying physical activity and BMI were associated with physical HRQoL group trajectories but not mental HRQoL trajectories. Moreover, smoking was associated with low groups in both physical and mental HRQoL trajectories but not declining HRQoL groups, additionally characterizing these HRQoL groups from one another. The ability to target prostate cancer survivors based on these characteristics may lead to enhanced HRQoL and survival outcomes long-term.
Based on v 2 analysis, there was a statistically significant association between the physical and mental HRQoL trajectories. The general pattern was for higher/maintaining physical HRQoL to be positively associated with higher/increasing mental HRQoL. These data suggest that physical and mental HRQoL trajectories in prostate cancer survivors are not independent, and that interventions to improve one component of HRQoL may also improve the other. Further research with a larger, more robust sample may be able to jointly model physical and mental HRQoL trajectories directly to confirm these findings.
Our analysis that modelled dropout produced significantly higher dropout probabilities in both the physical and mental low HRQoL groups relative to the other groups. Clinical implications of these findings support interventions for these specific groups of prostate cancer survivors. Specifically, for the very low-maintaining physical HRQoL group, scores were consistently below 30, which is well below the mean score of 50. 36 The very low-maintaining physical HRQoL group was older, more likely to be on hormone therapy, have undergone a prostatectomy, have comorbidities, higher BMI and more likely to be current smokers compared to the averagemaintaining HRQoL group. These differences characterize the very low-maintaining HRQoL group, however, confirmation of these findings is warranted to rule out the possibility of dropout artificially influencing trajectory groups.
There are limitations that should be noted in our study. Confounding by indication can occur in observational studies where other factors, in this case co-morbid conditions, general health and age, may alter survivors' baseline risk, thus explaining their HRQoL group membership, rather than the diagnosis of prostate cancer itself. For example, older prostate cancer survivors are more likely to have co-morbid conditions and less overall general health, resulting in a lower baseline for HRQoL scores after prostate cancer diagnosis.
While the SF-36 questionnaire is commonly used in health research, according to a recent systematic review examining quality of life tools specifically in prostate cancer patients, 37 there was a lack of data regarding certain psychometrics including criterion validity, reproducibility, responsiveness and uncertainty towards content validity. Therefore, further research is needed to replicate these results using prostate cancer-specific measures of HRQoL to avoid spurious conclusions. We had sufficient power to identify trajectory groups using GBTM methods, however, when examining prognostic and behavioural associations between groups, precision was lacking and therefore, chance of type II error is present. This situation may be especially relevant in the low-increasing and above average-declining mental HRQoL trajectory groups, representing <35% of the study population. Moreover, our study only had three repeated measurements over the postdiagnosis period of two and up to 10 years post-diagnosis. We made the assumption that HRQoL remained consistent between follow-up time-points of up to 2 years postdiagnosis. In between follow-up time-points participants may experience response shift as perceptions and priorities of HRQoL change over time. 38, 39 However, time-lagged exploratory models found that previous HRQoL score did predict future HRQoL scores and sensitivity analyses did not materially change results, therefore, these concerns are attenuated. Finally, our results may only apply to prostate cancer survivors who survived at least 2 to 3 years post-diagnosis and those with stage T2 or higher disease. Although this issue limits our generalizability, it was necessary to define a homogeneous population.
While it is important to take into account limitations, our study strengths need also be recognized when interpreting these results. Our study is the first to identify separate groups of prostate cancer survivors following different post-diagnosis physical and mental HRQoL trajectories. This innovative analysis technique is limited to just one distributional assumption with possible censoring due to ceiling and floor effects of HRQoL scores over time. In addition, we addressed biases inherent in long-term prospective cohort studies by identifying the role of dropout during active data collection. Dropout proved to be important in our study population and should be controlled for in future studies. Finally, we attempted to systematically characterize trajectory groups associations by behavioural/prognostic factors.
Based on these analyses there were three distinct trajectories of physical and mental HRQoL up to 10 years postprostate cancer diagnosis. Confirmation of these trajectory groups found and validation of characterizing behavioural/ prognostic factors related to the trajectory groups is warranted in other prostate cancer populations. Furthermore, future research examining changes in behavioural and prognostic variables long-term, specifically changes in prostate cancer treatment status (e.g., resuming radiation therapy) or development of additional comorbidities over time in conjunction with HRQoL may provide further insights into the experiences of prostate cancer survivors over time. If these or similar subgroups are found in future research, tertiary prevention intervention studies could focus on at-risk groups, who would benefit from interventions aimed to help improve or maintain HRQoL after prostate cancer diagnosis and, overall, reduce the burden of prostate cancer after diagnosis. If subgroups at risk for HRQoL declines can be identified early after prostate cancer diagnosis, long-term HRQoL may be maintained through interventions targeting their physical activity levels, [40] [41] [42] treatment regimens offered post-diagnosis 43, 44 and possibly psychosocial interventions. 45 Establishing subgroups of prostate cancer survivors who are truly experiencing low and/or declining HRQoL long-term after a diagnosis may be beneficial for future interventions to improve supportive care after prostate cancer.
